about
Lactate kinetics in sepsis and septic shock: a review of the literature and rationale for further researchα1 Antitrypsin deficiency: current best practice in testing and augmentation therapy.Ivacaftor Therapy in CF Patients: Single Center Experience.Prognostic utility of plasma lactate measured between 24 and 48 h after initiation of early goal-directed therapy in the management of sepsis, severe sepsis, and septic shockA rare case of disseminated Sporothrix schenckii with bone marrow involvement in a patient with idiopathic CD4 lymphocytopenia.Therapeutics: Alpha-1 Antitrypsin Augmentation Therapy.The Utility of the "Shred Sign" in the Diagnosis of Acute Respiratory Distress Syndrome Resulting from Multifocal Pneumonia.
P50
Q26786504-02456C1F-3114-48BF-B91B-85677ABAF0C7Q34428735-B2C2985B-A188-4EEA-A60F-3F89B7D452FDQ36112663-A3820223-CD5F-4969-B6E4-29EF1B4C2C04Q36574855-2FBFF1ED-B086-4419-A389-585BFFA935BDQ40972645-CCEA0DA3-9B9F-4144-980F-78AA9A4B56B2Q47703811-B976C6E4-03A4-4C39-84CE-D2182616B828Q48294824-21376A40-92D8-4477-A882-3A73F6433BCC
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Jorge Lascano
@en
Jorge Lascano
@nl
type
label
Jorge Lascano
@en
Jorge Lascano
@nl
prefLabel
Jorge Lascano
@en
Jorge Lascano
@nl
P31
P496
0000-0002-9546-1867